Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 21.3T | 23.1T | 24.8T | 23.9T |
| Cost of revenue | 19.5T | 21.1T | 22.7T | 21.6T |
| Gross profit | 1.8T | 2.0T | 2.1T | 2.3T |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 776.3B | 722.6B | 714.4B | 1.0T |
| Other operating expenses | 154.5B | 260.9B | 271.5B | 276.6B |
| Operating income | 209.8B | 305.7B | 36.1B | 260.3B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 99.0B | 120.3B | 61.5B | 78.6B |
| Other income expense | — | — | — | — |
| Pretax income | 99.3B | 195.1B | 23.2B | 126.5B |
| Tax provision | 86.5B | 87.6B | 34.6B | 59.8B |
| Net income | 12.7B | 107.5B | -11.4B | 66.7B |
| Basic EPS | — | 54 | — | — |
| Diluted EPS | — | 54 | — | — |
| Basic average shares | — | 1.9B | — | — |
| Diluted average shares | — | 1.9B | — | — |
| EBITDA | 402.5B | 528.9B | 309.9B | 423.4B |
| Net income from continuing op. | — | — | — | — |
| Minority interests | 4M | -3.1B | 0 | 2M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |